Columbia Univeristy-STARS
New York, 10019, United States
NCT Number: NCT03256253
The proposed protocol is an 8 week open label outpatient pilot trial of the safety and efficacy of pregabalin (Lyrica) in the treatment of alcohol use disorder. The primary objective of the study is to determine the efficacy of pregabalin in promoting alcohol abstinence among individuals with an alcohol use disorder.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 2
New York, 10019, United States
The proposed protocol is an open label outpatient pilot trial of the safety and efficacy of pregabalin (Lyrica) in the treatment of alcohol use disorder. Pregabalin is commonly used for the treatment of pain issues such as fibromyalgia (chronic pain in your body), diabetic nerve pain, spinal cord injury nerve, and pain after shingles. We plan to enroll 20 participants in an 8-week trial.The ideal dosing, tolerability, and safety of pregabalin will be tested in outpatients with Alcohol Use Disorder (AUD). The primary objective of the study is to determine the efficacy of pregabalin in promoting alcohol abstinence among individuals with an alcohol use disorder.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
pregabalin up to 600 mg/day
Other names: lyrica
Time frame: over the course of the 8 week trial or participants' length of participation
Defined as the highest amount of medication per day maintained for a 7 day period.
New York State Psychiatric Institute
Other
An Open-Label Pilot Study of Pregabalin as Treatment for Alcohol Use Disorder
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04523922
Alcohol Use Disorder, Alcohol-Related Disorders
Charleston, South Carolina, United States
View Trial DetailsNCT06817356
Alcohol Use Disorder, Alcohol-Related Disorders
Scottsdale, Arizona, United States
View Trial DetailsNCT05630118
Alcohol Use Disorder, Alcohol-Related Disorders
Lexington, Kentucky, United States
View Trial DetailsNCT06545929
Alcohol Use Disorder, Alcohol-Related Disorders
Columbus, Ohio, United States
View Trial Details